<DOC>
	<DOC>NCT01357135</DOC>
	<brief_summary>This is an observational study to compare the effectiveness of dual therapy of Type II diabetes mellitus with metformin + sitagliptin versus metformin + a sulfonylurea in routine clinical practice in France.</brief_summary>
	<brief_title>An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia速/Xelevia速, MK-0431-201)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Type 2 diabetes participants De novo treatment (first prescription or dated within the past 8 weeks) with: Metformin + sitagliptin dual therapy, Metformin + sulfonylurea dual therapy, Sitagliptin as part of another treatment regimen Participants also eligible for treatment with sitagliptin (Januvia速/Xelevia速) or a sulfonylurea.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>